About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 68526 record(s)
Req # A-2023-001092
Adverse Drug Reactions (ADRs). Report numbers: E2B_06622636, E2B_06621695.Organization: Health Canada
February 2024
Req # A-2023-001098
Adverse Drug Reaction (ADR). Report number: E2B_06564005.Organization: Health Canada
February 2024
Req # A-2023-001105
Adverse Drug Reactions (ADRs). Report numbers: E2B_06618356, 000395541.Organization: Health Canada
February 2024
Req # A-2023-001106
Adverse Drug Reactions (ADRs). Report numbers: E2B_06463857, E2B_06469205, E2B_06489055, E2B_06462329, E2B_06462780, E2B_06463776.Organization: Health Canada
February 2024
Req # A-2023-001114
Adverse Drug Reactions (ADRs). Report numbers: 001053384, E2B_06541156, E2B_06577728, E2B_06573217, E2B_06562499, 001054482, E2B_06547133, 001054612, E2B_06543824, 001054530.Organization: Health Canada
February 2024
Req # A-2023-001116
Adverse Drug Reactions (ADRs). Report numbers: 001058876, E2B_06578947.Organization: Health Canada
February 2024
Req # A-2023-001144
Adverse Drug Reactions (ADRs) for Entyvio. Report numbers: E2B_06606238, E2B_06610762, E2B_06605727, 001056184, 001055421. ADRs for Immunoglobulin (human). Report numbers: E2B_06638310, E2B_06620448, E2B_06628265, 001055123, E2B_06644736.Organization: Health Canada
February 2024
Req # A-2023-001150
Adverse Drug Reactions (ADRs) for C1 Esterase Inhibitor (Human). Report numbers: E2B_06602697,E2B_06617591, E2B_06645859, E2B_06619787, E2B_06636457. ADR for GAMMAGARD LIQUID. Report number: 001055423.Organization: Health Canada
February 2024
Req # A-2023-001151
Adverse Drug Reaction (ADR). Report number: 001059970.Organization: Health Canada
February 2024
Req # A-2023-001173
Adverse Drug Reaction (ADR). Report number: E2B_02997619.Organization: Health Canada
February 2024